APM
TMDX icon

Avidity Partners Management’s Transmedics TMDX Stock Holding History

Avidity Partners Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-192,400
Closed -$12M – 84
2024
Q4 		$12M Buy
192,400
+164,800
+597% +$15.3M 1.18% 36
2024
Q3 		$4.33M Buy
+27,600
New +$4.25M 0.22% 68
2022
Q4 		– Sell
-300,000
Closed -$12.5M – 102
2022
Q3 		$12.5M Buy
+300,000
New +$13M 0.25% 66

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Avidity Partners Management's TMDX Position: Q1 2025 in Review

Avidity Partners Management sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 192,400 shares — an estimated $12M sold.

Avidity Partners Management first reported a position in TMDX in Q3 2022 and held it in 3 quarters. The position peaked at $12.5M in Q3 2022. 298 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • Avidity Partners Management reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
  • Avidity Partners Management sold 192,400 Transmedics shares in Q1 2025, an estimated $12M.
  • Avidity Partners Management first reported a position in Transmedics in Q3 2022 and held it in 3 quarters.
  • Avidity Partners Management's Transmedics position peaked at $12.5M in Q3 2022.
  • 298 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Avidity Partners Management's 13F filing for Q1 2025, filed 15 May 2025.